• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORP. SINGLE USE GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORP. SINGLE USE GUIDEWIRE Back to Search Results
Model Number G-240-2545S
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Fistula (1862); Hemorrhage/Bleeding (1888); Respiratory Failure (2484)
Event Date 06/01/2023
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled " endoscopic ultrasound-guided gallbladder drainage: beyond cholecystitis.".Literature summary: endoscopic ultrasound-guided gallbladder drainage (eus-gbd) is an alternative to surgery for acute cholecystitis (ac) in poor operative candidates.However, the role of eus-gbd in non-cholecystitis (nc) indications has not been well studied.We compared the clinical outcomes of eus-gbd for ac and nc indications.Consecutive patients undergoing eus-gbd for all indications at a single center were retrospectively analyzed.Fifty-one patients underwent eus-gbd during the study period.Thirty-nine (76%) patients had ac while 12 (24%) had nc indications.Nc indications included malignant biliary obstruction (n = 8), symptomatic cholelithiasis (n = 1), gallstone pancreatitis (n = 1), choledocholithiasis (n = 1), and mirizzi¿s syndrome (n = 1).Technical success was noted in 92% (36/39) for ac and 92% (11/12) for nc (p > 0.99).The clinical success rate was 94% and 100%, respectively (p > 0.99).There were four adverse events in the ac group and 3 in the nc group (p = 0.33).Procedure duration (median 43 vs.45 min, p = 0.37), post-procedure length of stay (median 3 vs.3 days, p = 0.97), and total gallbladder-related procedures (median 2 vs.2, p = 0.59) were similar.Eus-gbd for nc indications is similarly safe and effective as eus-gbd in ac.Type of adverse events/number of patients: abdominal pain with hospitalization - 1 patient; bleeding requiring transfusions - 1 patient; bleeding requiring embolization of the gastroduodenal artery - 1 patient; pneumoperitoneum requiring exploratory laparotomy ¿ 1 patient; pneumoperitoneum requiring supportive care with intravenous fluids and antibiotics ¿ 1 patient; respiratory failure requiring ventilation and additional stay in the intensive care unit ¿ 1 patient; cholecystocolonic fistula requiring stent removal and gastric clips for closure ¿ 1 patient.Two patients had reportedly died.It was reported these deaths were unrelated to procedures or the devices in use during the procedures.This literature article requires 2 reports.The related patient identifiers are as follows: -b)(6): gf-uct180 evis exera ii ultrasound gastrovideoscope; (b)(6): g-240-2545s single use guidewire.This medical device report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINGLE USE GUIDEWIRE
Type of Device
SINGLE USE GUIDEWIRE
Manufacturer (Section D)
TERUMO CORP.
44-1, 2-chome, hatagaya
shibuya-ku, tokyo 151-0 072
JA  151-0072
MDR Report Key17556570
MDR Text Key321280833
Report Number2429304-2023-00259
Device Sequence Number1
Product Code OCY
UDI-Device Identifier04953170282782
UDI-Public04953170282782
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 07/18/2023,08/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberG-240-2545S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date07/18/2023
Event Location Hospital
Date Report to Manufacturer07/18/2023
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GF-UCT180 EVIS EXERA II GASTROVIDEOSCOPE
Patient Outcome(s) Required Intervention; Hospitalization;
-
-